Leva Clinic, the UK’s first fully digital clinic for pain management, is excited to announce its merger with Zerenia Clinic, a leading integrated healthcare provider. This will widen the level of treatment available to patients, particularly through the use of medical cannabis as a solution for managing chronic pain.
This partnership combines Leva Clinic’s expertise in pain management with Zerenia’s holistic healthcare approach, offering patients across the UK greater access to innovative treatments, personalised care, and a broader range of services, all tailored to individual needs. Leva and Zerenia will continue to operate as individual entities, ensuring a continuation of care and treatments for current patients.
Speaking about the merger, Guillermo Moreno-Sanz, PhD. from Zerenia said; “This merger strengthens the commitment we have to reduce the UK population’s reliance on opioids and other painkillers.
“With a growing focus on addressing the opioid crisis, this partnership provides an opportunity to offer alternative, sustainable pain management options. By integrating medical cannabis within a broader holistic care model, the goal is to provide long-term relief that tackles the root causes of pain rather than just the symptoms, ensuring patients receive more comprehensive, effective treatments.”
Zerenia’s patient-centred approach ensures continuity of care, while Leva Clinic’s digital platform provides easy access to consultations, treatment plans, and follow-ups. Together, the two clinics will provide an unparalleled level of service, improving patient outcomes in chronic pain management.
With Zerenia’s deep commitment to evidence-based treatments, patients will gain access to an expanded formulary, including medical cannabis options. This merger allows for greater advocacy and education on the effectiveness of medical cannabis in pain management, a critical message as skepticism remains high in the UK.
Eric Bystrom, CEO of Leva Clinic; said “I am incredibly excited to become part of Zerenia and its extensive healthcare group. This merger is a pivotal moment for us, marking a natural evolution from our collaboration through Project TWENTY21, where both of our organizations have been pioneers in UK medical cannabis. Our shared vision of patient-centered care and science-driven, personalized medicine has always been at the heart of our mission. Integrating with Zerenia will amplify our ability to offer innovative, evidence-based treatments and advocate for the benefits of medical cannabis in managing chronic pain.”
Franziska Katterbach, Director of Zerenia Clinic; “We are thrilled to announce this merger with Leva Clinic, a significant step in our strategy to expand our impact on patient care. Both of our organizations have been at the forefront of medical cannabis in the UK since the inception of Project TWENTY21, and we have always shared a vision of delivering patient-centric care through science-driven, personalized medicine. This partnership will allow us to integrate our pioneering approaches and continue leading the way in providing sustainable, evidence-based pain management solutions.
“Patients can expect continuity of care and access to the same high-quality services they’ve come to rely on. All medical records will remain secure, with the highest standards of data protection. The expanded service offerings from Zerenia will provide patients with new, evidence-based treatment options, including access to an extensive medical cannabis formulary.”
The post Leva Clinic Merges with Zerenia to Expand Patient Care and Promote Medical Cannabis as a Pain Management Solution appeared first on Business of Cannabis.
Continue reading...
This partnership combines Leva Clinic’s expertise in pain management with Zerenia’s holistic healthcare approach, offering patients across the UK greater access to innovative treatments, personalised care, and a broader range of services, all tailored to individual needs. Leva and Zerenia will continue to operate as individual entities, ensuring a continuation of care and treatments for current patients.
Speaking about the merger, Guillermo Moreno-Sanz, PhD. from Zerenia said; “This merger strengthens the commitment we have to reduce the UK population’s reliance on opioids and other painkillers.
“With a growing focus on addressing the opioid crisis, this partnership provides an opportunity to offer alternative, sustainable pain management options. By integrating medical cannabis within a broader holistic care model, the goal is to provide long-term relief that tackles the root causes of pain rather than just the symptoms, ensuring patients receive more comprehensive, effective treatments.”
Zerenia’s patient-centred approach ensures continuity of care, while Leva Clinic’s digital platform provides easy access to consultations, treatment plans, and follow-ups. Together, the two clinics will provide an unparalleled level of service, improving patient outcomes in chronic pain management.
With Zerenia’s deep commitment to evidence-based treatments, patients will gain access to an expanded formulary, including medical cannabis options. This merger allows for greater advocacy and education on the effectiveness of medical cannabis in pain management, a critical message as skepticism remains high in the UK.
Eric Bystrom, CEO of Leva Clinic; said “I am incredibly excited to become part of Zerenia and its extensive healthcare group. This merger is a pivotal moment for us, marking a natural evolution from our collaboration through Project TWENTY21, where both of our organizations have been pioneers in UK medical cannabis. Our shared vision of patient-centered care and science-driven, personalized medicine has always been at the heart of our mission. Integrating with Zerenia will amplify our ability to offer innovative, evidence-based treatments and advocate for the benefits of medical cannabis in managing chronic pain.”
Franziska Katterbach, Director of Zerenia Clinic; “We are thrilled to announce this merger with Leva Clinic, a significant step in our strategy to expand our impact on patient care. Both of our organizations have been at the forefront of medical cannabis in the UK since the inception of Project TWENTY21, and we have always shared a vision of delivering patient-centric care through science-driven, personalized medicine. This partnership will allow us to integrate our pioneering approaches and continue leading the way in providing sustainable, evidence-based pain management solutions.
“Patients can expect continuity of care and access to the same high-quality services they’ve come to rely on. All medical records will remain secure, with the highest standards of data protection. The expanded service offerings from Zerenia will provide patients with new, evidence-based treatment options, including access to an extensive medical cannabis formulary.”
The post Leva Clinic Merges with Zerenia to Expand Patient Care and Promote Medical Cannabis as a Pain Management Solution appeared first on Business of Cannabis.
Continue reading...